Study of 0.4% povidone-iodine nasal spray for SARS-CoV-2
Evaluatig the virucidal efficacy of 0.4% povidone-iodine nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes, 4 hours after PVP-I exposure.
Samut Sakhon Mahidol University Guidelines For Reporting Parallel Group Randomised Trials Sun Yat Sen University Siriraj Hospital Samut Sakhon Hospital
Source: dovepress.com